Coherus BioSciences CHRS Q2 2025 earnings
Reported August 7, 2025 · After market close
Revenue$10.3MMiss by $1.7M
EPS-$0.34Miss by $0.03
Revenue estimate$12.0M
EPS estimate-$0.31
Next report
Aug 5, 2026 (In 1 week)Revenue estimate$14.4M
EPS estimate-$0.12
Versus estimates
Revenue
Diluted EPS
Ask the moment Coherus BioSciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Coherus BioSciences report Q2 2025 earnings?
- Coherus BioSciences (CHRS) reported Q2 2025 earnings on August 7, 2025 after market close.
- What were Coherus BioSciences's Q2 2025 revenue and EPS?
- Coherus BioSciences reported revenue of $10.3M and eps of $-0.34 for Q2 2025.
- Did Coherus BioSciences beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $12.0M by $1.7M. EPS missed the consensus estimate of $-0.31 by $0.03.
- How did Coherus BioSciences's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 84.2% from $65.0M a year earlier and eps declined 142.9% from $-0.14.
- Where can I find Coherus BioSciences's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-010803) directly on SEC EDGAR. The filing index links above go to sec.gov.